Protective effect of caffeine and a selective A2A receptor antagonist on impairment of memory and oxidative stress of aged rats

Experimental Gerontology
Marlon Régis LeiteCristina W Nogueira

Abstract

In this study, the effects of caffeine (CAF) and SCH58261, a selective A(2A) receptor antagonist, on memory impairment and oxidative stress generated by aging in rats were investigated. Young and aged rats were treated daily per 10 days with CAF (30 mg/kg p.o.) or SCH58261 (0.5mg/kg, p.o.) or vehicle (1 ml/kg p.o.). Rats were trained and tested in a novel object recognition task. After the behavioral test, ascorbic acid and oxygen and nitrogen reactive species levels as well as Na(+)K(+) ATPase activity were determined in rat brain. The results demonstrated that the age-related memory deficit was reversed by treatment with CAF or SCH58261. Treatment with CAF or SCH58261 significantly normalized oxygen and nitrogen reactive species levels increased in brains of aged rats. Na(+)K(+) ATPase activity inhibited in brains of aged rats was also normalized by CAF or SCH58261 treatment. A decrease in basal ascorbic acid levels in brains of aged rats was not changed by CAF or SCH58261. These results demonstrated that CAF and SCH58261, modulators of adenosinergic receptors, were able to reverse age-associated memory impairment and to partially reduce oxidative stress.

References

Jan 1, 1991·Journal of Neurochemistry·P VianiB Cestaro
Feb 1, 1989·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M Erecińska, I A Silver
Nov 1, 1988·Behavioural Brain Research·A Ennaceur, J Delacour
Sep 1, 1994·Neuroscience·A de Mendonça, J A Ribeiro
Mar 8, 1996·Chemico-biological Interactions·M A CarfagnaB B Muhoberac
Apr 1, 1996·Drugs & Aging·W J Riedel, J Jolles
Nov 1, 1996·Biochemical Society Transactions·B Halliwell
Jul 15, 1998·American Journal of Epidemiology·M PaleologosR Lazarus
Jul 22, 1999·European Journal of Pharmacology·M E AngelucciC Da Cunha
Feb 17, 2000·Neurochemistry International·P AgostinhoC R Oliveira
Jan 5, 2001·Psychopharmacology·K P CorodimasJ M Stieg
Jun 28, 2001·Brain Research Bulletin·M S GevaerdC Da Cunha
Jan 25, 2003·Experimental Gerontology·C A Erickson, C A Barnes
Mar 5, 2003·Neuroscience Letters·Cláudia G AlmeidaJ Alexandre Ribeiro
Apr 30, 2003·Neurochemical Research·Caren S BavarescoAngela T S Wyse
May 13, 2003·Synapse·Nadja SchröderJohn F Marshall
Jun 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ruolan LiuMichel Baudry
Aug 9, 2003·Journal of Neurophysiology·Nelson RebolaRodrigo A Cunha
Dec 4, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Tomoaki SatoTakashige Nishikawa
Jan 27, 2004·Physiology & Behavior·Angela T S WyseCarlos A Netto
Feb 24, 2004·Neurological Research·Hua ZhanKazuhiro Hongo
Mar 31, 2005·International Review of Neurobiology·Bertil B FredholmJean-Marie Vaugeois
Jun 7, 2005·Experimental Gerontology·Maria Noêmia M de LimaNadja Schröder
Nov 22, 2005·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Ionara Rodrigues SiqueiraCarlos Alexandre Netto
May 19, 2006·Behavioural Brain Research·Jun LuYou-jian Feng
Nov 28, 2006·Experimental Gerontology·Thanasekaran JayakumarPitchairaj Geraldine
May 8, 2007·Neurobiology of Aging·Ricardo J RodriguesRodrigo A Cunha
May 23, 2007·Aging Cell·Wulf Dröge, Hyman M Schipper
Jul 28, 2007·Journal of Agricultural and Food Chemistry·José Angel Gómez-RuizJennifer M Ames

❮ Previous
Next ❯

Citations

Mar 19, 2014·Experimental Gerontology·Marlon R LeiteGilson Zeni
Nov 22, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Marco MatosJiang-Fan Chen
Dec 3, 2014·Molecular Psychiatry·C LaurentD Blum
Oct 1, 2015·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Adejoke Yetunde Onaolapo, Olakunle James Onaolapo
Mar 15, 2013·Neurochemistry International·Mauren Assis SouzaLuiz Fernando Freire Royes
Jun 23, 2016·Canadian Journal of Physiology and Pharmacology·Ionut CaravanGabriela Adriana Filip
Jul 2, 2016·Journal of Neurochemistry·Rodrigo A Cunha
Nov 29, 2016·PloS One·Gabriela Hurtado-AlvaradoBeatriz Gómez-González
May 20, 2017·Journal of Toxicology and Environmental Health. Part a·Adriani Paganini DamianiVanessa Moraes de Andrade
Jun 20, 2016·AIMS Public Health·Yenisetti Sc, Muralidhara
Oct 22, 2020·Journal of Food Biochemistry·Smriti TripathiPapiya Mitra Mazumder
Dec 31, 2020·International Journal of Molecular Sciences·Katarzyna SocałaPiotr Wlaź
Oct 3, 2018·Aging and Disease·Diano F MarroneAnuj Patel
Aug 8, 2021·International Journal of Molecular Sciences·Min ShinSrdjan M Vlajkovic
Oct 7, 2018·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Naiara StefanelloMaria Rosa Chitolina Schetinger
Sep 18, 2012·Learning & Memory·Fernando Gámiz, Milagros Gallo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.